BDP5290

Overview

BDP5290 is a potent inhibitor of both ROCK and MRCK with IC 50 s of 5 nM, 50 nM, 10 nM and 100 nM for ROCK1 , ROCK2 , MRCKα and MRCKβ , respectively.

Application

Products | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Pulmonary Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > ROCK

Product Information

• Catalog No.: HY-12437
• CAS No.: 1817698-21-7
• Molecular Formula: C17H18ClN7O
• Molecular Weight: 371.82
• Purity: 98.90%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Availability: In-stock

Source

Original product source